The global micro needle patch market was valued at approximately USD 725.17 million in 2022 and is projected to grow at a healthy rate of more than 6.1% over the forecast period from 2023 to 2030.
for its dissolvable Doxorubin-containing microneedle array, D-MNA, to treat external squamous cell carcinoma, SCC, in horses. The company received a notification from the FDA on December 9th 2024.
After speaking to people about the German Market last month, one word that stuck with me was 'ritual'. If you go to the market year after year, chances are you might have your own ritual too.
10, 2024. (AP Photo/Peter Morgan, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] NEW YORK (AP) — U.S. stock indexes drifted lower Tuesday in the runup to the highlight of ...
CeraMaps, the company's drug delivery platform, is based on ceramic microneedle array patches (CeraMAPs™). This technology was initially developed at the University of Twente's MESA+ Institute ...